NYSEAMERICAN : AZTR
Azitra, Inc. — Key statistics
Healthcare · Biotechnology · United States
Last price 0.7 USD (Oct 30, 2026, 9:41 AM EDT) · Market cap 4.24M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 4.66M |
| Enterprise Value | -1.66M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 16, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 6.06M |
| Shares Outstanding | 6.06M |
| Shares Change (YoY) | +672.11% |
| Shares Change (QoQ) | +24.38% |
| Owned by Insiders (%) | 6.71% |
| Owned by Institutions (%) | 23.85% |
| Float | 5.13M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.64 |
| P/TBV Ratio | 0.67 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 4.86 |
| Quick Ratio | 4.49 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,164.70 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -256.67% |
| Return on Assets (ROA) | -119.91% |
| Return on Invested Capital (ROIC) | -146.29% |
| Return on Capital Employed (ROCE) | -167.20% |
| Weighted Average Cost of Capital (WACC) | -1.18% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$944,072 |
| Employee Count | 13 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 8,319 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | -1.04 |
| 52-Week Price Change | -84.55% |
| 50-Day Moving Average | 1.48 |
| 200-Day Moving Average | 1.92 |
| Relative Strength Index (RSI) | 36.92 |
| Average Volume (20 Days) | 8,109,852 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 11,229 |
| Short Previous Month | 70,134 |
| Short % of Shares Out | 0.19% |
| Short % of Float | 0.22% |
| Short Ratio (days to cover) | 0.15 |
Incomestatement
| Measure | Value |
|---|
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -12.35M |
| Pretax Income | -12.26M |
| Net Income | -12.27M |
| EBITDA | -12.20M |
| EBIT | -12.35M |
| Earnings Per Share (EPS) | -$9.84 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 6.73M |
| Total Debt | 410,053 |
| Net Cash | 6.32M |
| Net Cash Per Share | $1.04 |
| Equity (Book Value) | 7.33M |
| Book Value Per Share | 1.21 |
| Working Capital | 5.91M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -11.11M |
| Capital Expenditures | -67,593 |
| Depreciation & Amortization | 146,261 |
| Net Borrowing | -16,848 |
| Free Cash Flow | -11.17M |
| FCF Per Share | -$1.84 |
Margins
| Measure | Value |
|---|
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -672.11% |
| Shareholder Yield | -672.11% |
| Earnings Yield | -1,278.76% |
| FCF Yield | -239.69% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $6.70 |
| Price Target Difference | 771.04% |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Oct 26, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |